Tools
iPIE
The project iPIE: "Intelligence Led Assessment of Pharmaceuticals in the Environment", aims to develop a predictive framework that utilise existing information and in silico models to support more intelligent environmental testing of pharmaceuticals in development and to prioritise legacy pharmaceuticals for full environmental risk assessment and/or environmental (bio) monitoring. European project funded by IMI for the period 2015-2019.
MedBioinformatics
The project MedBioinformatics "Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities" aims to develop useful bioinformatics tools and applications, and autonomously usable for analysing the huge amount of data and knowledge generated in healthcare and biomedical research in order to facilitate translational research and precision medicine. European project funded by H2020 for the period 2015-2018 and coordinated by the GRIB.
EMIF
The EMIF project aims to develop a common information framework of patient-level data that will link up and facilitate access to diverse medical and research data sources, opening up new avenues of research for scientists. To provide a focus and guidance for the development of the framework, the project will focus initially on questions relating to obesity and Alzheimer’s disease. EMIF is a European project funded by IMI.
eTOX
Integrating bioinformatics and chemoinformatics approaches for the development of expert systems allowing the in silico prediction of toxicities. European project funded by IMI, extended until 2016 and coordinated by the GRIB. The eTOX project aims to develop a drug safety database from the pharmaceutical industry legacy toxicology reports and public toxicology data, innovative in silico strategies and novel software tools to better predict the toxicological profiles of small molecules in early stages of the drug development pipeline.
Open PHACTS
The Open Pharmacological Concepts Triple Store project (Open PHACTS) will develop an open access innovation platform, called Open Pharmacological Space (OPS), via a semantic web approach. OPS will be comprised of data, vocabularies and infrastructure needed to accelerate drug- oriented research. The aim is to develop an enabling resource for drug discovery projects which is open to all users and freely available in the public domain. This european project is funded by IMI and has been recently extended until 2016.
Consolider RNAREG
RNAREG is a consortium of research groups financed by the Consolider Ingenio Program from the Spanish Ministry of Science and Innovation for the period 2010-2015. The focus of the consortium is the study of post-transcriptional regulation of gene expression and the impact of de-regulation of these processes in human disease, particularly in cancer.
RNPnet
RNAs associate with proteins to form highly complex and dynamic ribonucleoprotein (RNP) complexes. The goal of this Marie Curie ITN is first to bring together existing labs from different discipline, to join forces and tackle key questions in the field, and second, to produce highly-trained young researchers that will be sensitized to RNA and possess a multidisciplinary approach to research.
INBIOMEDvision
The aim of this european project of the 7th FP is to promote Biomedical Informatics by means of the permanent monitoring of the scientific state-of-the-art and existing activities in the theme, prospective analysis of the emerging challenges and opportunities, and dissemination of the knowledge in the field. The project is coordinated by the GRIB.
ARITMO
ARITMO arose out of the need to identify not only which medications prolong the QT interval, but also those that can cause serious side effects as well as discover the factors that are associated with this risk. The objective of the project is to provide doctors with better guidance when making drug prescription decisions. European project funded by the 7th FP.
ActivA
An innovative project to pave the way for integration of the data coming from the patient with the results that the researcher obtains from it, ensuring the quality control and the rational of this flow of information in both directions thanks to the clinicians involvement
